908 organization(s) found
Innate Pharma
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: antibody Drug Conjugates (ADC), monoclonal antibodies (mAbs) and multi-specific NK Cell Engagers through its proprietary ANKET® (Antibody-based NK cell Engager Therapeutics) platform.
Innovent Biologics
Innovent Biologics is a leading biopharmaceutical company founded in 2011 with the mission to provide high-quality biologics that are affordable to all. Through our hallmark integrated approach, state-of-the-art manufacturing facilities and strategic collaborations, we are involved in every stage of a drug's lifecycle, from discovery to development to commercialization, allowing us to build robust pipelines for innovative drugs that treat cancer and other major diseases.
Institut Cochin
Biomedical research institute in Paris with teams working on normal and malignant blood cell development.
Institut Curie
Made up of an internationally renowned Research Center and a cutting-edge Hospital Group, Institut Curie, the first French cancer center, treats all cancers, even the most rare forms.
Institut de la Leucémie Paris Saint-Louis
In French: "L’Institut de la Leucémie est un Institut Hospitalo-Universitaire (IHU) fondé en 2023 par l’Assistance Publique–Hôpitaux de Paris, l’INSERM, le Collège de France et l’Université Paris Cité et abrité par la Fondation Université Paris Cité (FUPC). Il incarne une dynamique collaborative sans précédent, réunissant des expertises cliniques et scientifiques autour d’une ambition commune : transformer la prise en charge des patients atteints de leucémies aiguës et maladies apparentées."
Institut du Cancer Paris CARPEM
In French: "Pour une meilleure prise en charge des patients atteints de cancer, AP-HP.Centre – Université Paris Cité et le SIRIC CARPEM ont créé l’Institut du Cancer Paris CARPEM. Il réunit les activités liées à la prise en charge des patients adultes atteints de cancer de tous nos hôpitaux, et regroupe ainsi les forces du GHU AP-HP.Centre-Université Paris Cité en soins, recherche et enseignement. L’Institut est accrédité « Comprehensive Cancer Center » par l’Organisation des Instituts européens du Cancer (OECI). Cette accréditation, délivrée pour 5 ans, récompense l’engagement et l’excellence des équipes impliquées dans la prise en charge des patients atteints de cancer."
Institut Godinot
French comprehensive cancer centre, member of the Unicancer network.
Institut Pasteur
French private non-profit foundation for biomedical research.
International Myeloma Foundation (IMF)
Non-profit organisation that supports myeloma patients and funds research.
IOR
The Institute of Oncology Research (IOR), located in Bellinzona (Switzerland) and directed by Prof. Andrea Alimonti, hosts researchers from all over the world performing basic and translational research in oncology with special focus on cancer biology, genomics, molecular oncology and experimental therapeutics. The IOR is affiliated to the Università della Svizzera italiana (USI) and is located in a brand-new high-tech research building that hosts more than 20 different research groups, with state-of-the-art labs and facilities.
Iovance Biotherapeutics
Iovance Biotherapeutics is pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient.
IPO Lisboa (Instituto Português de Oncologia de Lisboa Francisco Gentil)
Portuguese public cancer institute in Lisbon.